Loading…
Prospective metabolomics study identifies potential novel blood metabolites associated with pancreatic cancer risk
Using a metabolomics approach, we systematically searched for circulating metabolite biomarkers for pancreatic cancer risk in a case‐control study nested within two prospective Shanghai cohorts. Included in our study were 226 incident pancreatic cancer cases and their individually‐matched controls....
Saved in:
Published in: | International journal of cancer 2018-11, Vol.143 (9), p.2161-2167 |
---|---|
Main Authors: | , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Using a metabolomics approach, we systematically searched for circulating metabolite biomarkers for pancreatic cancer risk in a case‐control study nested within two prospective Shanghai cohorts. Included in our study were 226 incident pancreatic cancer cases and their individually‐matched controls. Untargeted mass spectrometry platforms were used to measure metabolites in blood samples collected prior to cancer diagnosis. Conditional logistic regression was performed to assess the associations of metabolites with pancreatic cancer risk. We identified 10 metabolites associated with pancreatic cancer, after accounting for multiple comparisons (the Benjamini‐Hochberg false discovery rate |
---|---|
ISSN: | 0020-7136 1097-0215 |
DOI: | 10.1002/ijc.31574 |